External Control Arms and Tokenization: From RCTs to RWE
Time: 12:00 pm
day: Pre-Conference Day
Details:
ECAs, often derived from RWD, provide a complementary approach to RCTs by allowing comparisons without the need for new control groups, thus enhancing efficiency and reducing costs. Tokenization, a data privacy method, enables secure linking of patient data across different sources, bridging the gap between RCTs and real-world evidence (RWE). This workshop delves into the opportunities and challenges of leveraging these methods in clinical research.
- Explore how ECAs, using real-world data, can supplement or replace traditional control groups in clinical trials, improving efficiency and reducing patient burden.
- Understand how tokenization securely links patient data from multiple sources, enabling seamless integration of real-world evidence (RWE) with randomized controlled trials (RCTs).
- Discuss the benefits and challenges of combining RCTs and RWE through ECAs and tokenization to enhance clinical trial design and outcomes.
